Matched Unrelated Donor (MUD)
Showing 1 - 25 of 6,735
Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation
Not yet recruiting
- Acute Leukemia
- +4 more
- Haploidentical hematopoietic cell transplantation (haploHCT)
- matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
- (no location specified)
Jul 13, 2022
Multiple Myeloma Trial in Hamburg (allogeneic HSCT)
Completed
- Multiple Myeloma
- allogeneic HSCT
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Sep 1, 2022
Idiopathic Aplastic Anemia, Severe Aplastic Anemia, Moderate Aplastic Anemia Requiring Transfusions Trial (HSCT Arm group)
Not yet recruiting
- Idiopathic Aplastic Anemia
- +2 more
- HSCT Arm group
- (no location specified)
Jun 10, 2022
Chronic Granulomatous Disease, CGD Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (JSP191)
Recruiting
- Chronic Granulomatous Disease
- CGD
- JSP191
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 5, 2023
Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Enrolling by invitation
- Severe Combined Immune Deficiency (SCID)
- Sirolimus
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Severe Aplastic Anemia Trial in United States (drug, procedure, radiation)
Active, not recruiting
- Severe Aplastic Anemia
- cyclosporine
- +8 more
-
Los Angeles, California
- +12 more
Feb 10, 2022
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Chicago (Haplo-Cord Transplant, Matched Unrelated Donor
Terminated
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
- Haplo-Cord Transplant
- Matched Unrelated Donor Transplant
-
Chicago, IllinoisUniversity of Chicago Cancer Center
Feb 22, 2021
Immunodeficiencies Trial in Philadelphia (CliniMACs)
Active, not recruiting
- Immunodeficiencies
- CliniMACs
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Mar 1, 2022
Blood Stem Cell Transplant Failure, Leukemia, Hematologic Malignancies Trial in Houston (Cyclophosphamide, Fludarabine,
Completed
- Blood Stem Cell Transplant Failure
- +2 more
- Cyclophosphamide
- +9 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 12, 2020
Acquired Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Inherited Bone Marrow Failure Syndromes Trial in Philadelphia
Recruiting
- Acquired Aplastic Anemia
- +2 more
- CliniMACs
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 1, 2022
Immunodeficiencies, Immune Dysregulation Syndromes Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using CliniMACS
Recruiting
- Immunodeficiencies
- Immune Dysregulation Syndromes
- Apha/beta T and CD19+ cell depletion using CliniMACS device
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Nov 8, 2022
Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))
Not yet recruiting
- Leukemia
- +12 more
- Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
- (no location specified)
Mar 20, 2023
Samples and Data for National Marrow Donor Program Repository
Recruiting
- Bone Marrow Transplantation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 1, 2022
Hematologic Malignancies Trial in Milwaukee (CliniMACs)
Active, not recruiting
- Hematologic Malignancies
- CliniMACs
-
Milwaukee, WisconsinChildren's Hospital of Wisconsin
Apr 4, 2022
Inherited Immune Deficiencies Trial run by the NIAID (Campath 1H, Busulfan, Horse Anti-human Thymocyte Globulin (h-ATG))
Completed
- Inherited Immune Deficiencies
- Campath 1H
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 20, 2021
Sickle Cell Disease, Thalassemia Major Trial in Philadelphia (CliniMACS)
Recruiting
- Sickle Cell Disease
- Thalassemia Major
- CliniMACS
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Dec 22, 2021
Leukemia, Lymphoma, Myelodysplasia Trial in Philadelphia (Alpha Beta T cell depletion)
Recruiting
- Leukemia
- +2 more
- Alpha Beta T cell depletion
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Oct 27, 2021
AML, ALL, MDS Trial in Germany (Peripheral blood stem cells)
Recruiting
- AML
- +2 more
- Peripheral blood stem cells
-
Bonn, Germany
- +8 more
Aug 25, 2021
Leukemia, Bone Marrow Failure Syndrome, Immunodeficiencies Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using
Available
- Leukemia
- +2 more
- Apha/beta T and CD19+ cell depletion using CliniMACS device
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Nov 2, 2021
Hematologic Diseases Trial in Palo Alto (Allogeneic Stem Cell Transplant, CliniMACS TCR a/ß Reagent Kit and CliniMACS CD19)
Recruiting
- Hematologic Diseases
- Allogeneic Stem Cell Transplant
- CliniMACS TCR α/β Reagent Kit and CliniMACS CD19
-
Palo Alto, CaliforniaLucile Packard Children's Hospital
Feb 2, 2022
Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)
Active, not recruiting
- Chronic Granulomatous Disease Transplant
- Alemtuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)
Not yet recruiting
- Graft Vs Host Disease
- +5 more
- CliniMACS® device
- (no location specified)
Jul 20, 2023
Malignant Diseases (ie, Leukemia, MDS, Lymphoma), Non-malignant Diseases (ie, Bone Marrow Failure Syndromes) Trial in Milwaukee
Completed
- Malignant Diseases (ie, Leukemia, MDS, Lymphoma)
- Non-malignant Diseases (ie, Bone Marrow Failure Syndromes)
- CliniMACS (CD+3, CD+19 depletion)
- +2 more
-
Milwaukee, WisconsinChildren's Hospital of Wisconsin
Oct 21, 2021